The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity

被引:166
作者
Ovsyannikova, Inna G. [1 ]
Haralambieva, Iana H. [1 ]
Crooke, Stephen N. [1 ]
Poland, Gregory A. [1 ]
Kennedy, Richard B. [1 ]
机构
[1] Mayo Clin, Vaccine Res Grp, Guggenheim Bldg 611C,200 First St SW, Rochester, MN 55905 USA
关键词
alleles; coronavirus; COVID-19; genes; genetic variation; genome-wide association study; GWAS; HLA; immunogenetics; polymorphisms; single nucleotide; SARS; SARS-CoV-2; severe acute respiratory syndrome; systems biology; vaccine; ACUTE-RESPIRATORY-SYNDROME; MANNOSE-BINDING LECTIN; MIGRATION INHIBITORY FACTOR; CLASS-II ALLELES; SYNDROME-CORONAVIRUS; DC-SIGN; FUNCTIONAL POLYMORPHISMS; CLINICAL CHARACTERISTICS; HONG-KONG; ASSOCIATION;
D O I
10.1111/imr.12897
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This article provides a review of studies evaluating the role of host (and viral) genetics (including variation in HLA genes) in the immune response to coronaviruses, as well as the clinical outcome of coronavirus-mediated disease. The initial sections focus on seasonal coronaviruses, SARS-CoV, and MERS-CoV. We then examine the state of the knowledge regarding genetic polymorphisms and SARS-CoV-2 and COVID-19. The article concludes by discussing research areas with current knowledge gaps and proposes several avenues for future scientific exploration in order to develop new insights into the immunology of SARS-CoV-2.
引用
收藏
页码:205 / 219
页数:15
相关论文
共 166 条
[1]   Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease [J].
Agostini, Maria L. ;
Andres, Erica L. ;
Sims, Amy C. ;
Graham, Rachel L. ;
Sheahan, Timothy P. ;
Lu, Xiaotao ;
Smith, Everett Clinton ;
Case, James Brett ;
Feng, Joy Y. ;
Jordan, Robert ;
Ray, Adrian S. ;
Cihlar, Tomas ;
Siegel, Dustin ;
Mackman, Richard L. ;
Clarke, Michael O. ;
Baric, Ralph S. ;
Denison, Mark R. .
MBIO, 2018, 9 (02)
[2]   Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies [J].
Ahmed, Syed Faraz ;
Quadeer, Ahmed A. ;
McKay, Matthew R. .
VIRUSES-BASEL, 2020, 12 (03)
[3]  
[Anonymous], 2019, VIRUSES BASEL, DOI [DOI 10.3390/V11030280, DOI 10.3390/v11030280]
[4]  
Ansari MA, 2020, GENE LOCUS CONTROLS, DOI [10.1101/2020.04.26.20080408, DOI 10.1101/2020.04.26.20080408]
[5]  
Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]
[6]   A Meta-analysis of MBL2 Polymorphisms and Tuberculosis Risk [J].
Areeshi, Mohammed Y. ;
Mandal, Raju K. ;
Akhter, Naseem ;
Dar, Sajad A. ;
Jawed, Arshad ;
Wahid, Mohd ;
Mahto, Harishankar ;
Panda, Aditya K. ;
Lohani, Mohtashim ;
Haque, Shafiul .
SCIENTIFIC REPORTS, 2016, 6
[7]   ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy [J].
Asselta, Rosanna ;
Paraboschi, Elvezia Maria ;
Mantovani, Alberto ;
Duga, Stefano .
AGING-US, 2020, 12 (11) :10087-10098
[8]   Neurological manifestations in COVID-19 caused by SARS-CoV-2 [J].
Baig, Abdul Mannan .
CNS NEUROSCIENCE & THERAPEUTICS, 2020, 26 (05) :499-501
[9]   SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate [J].
Becerra-Flores, Manuel ;
Cardozo, Timothy .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2020, 74 (08)
[10]   Identification of New Respiratory Viruses in the New Millennium [J].
Berry, Michael ;
Gamieldien, Junaid ;
Fielding, Burtram C. .
VIRUSES-BASEL, 2015, 7 (03) :996-1019